Shift in the profile and prognostic implications in invasive fungal rhinosinusitis: experience of 10 years in a tertiary center
Open Access
- 3 February 2025
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 41 (1) , 1-8
Abstract
Background: Despite appropriate treatment, mortality of acute invasive fungal rhinosinusitis remains exceedingly high, surpassing 50%. Evidence on how to optimize its management is still limited. We present a case series from our institution aiming to fill the knowledge gap. Methods: A retrospective descriptive study was conducted, selecting cases treated at our institution between January 2012 and January 2022. The following variables were analyzed: gender, age, underlying conditions, symptoms, histological study outcomes, microbiological study outcomes, administered antifungal treatment, surgical interventions, and survival following diagnosis. Results: Seventeen patients were included in our study. The mean age was 55 years, with 12 males and 5 females. The most frequents underlying conditions were hematological malignancies (76.5%) and solid organ transplantation (11.8%). Surgical interventions were performed on 15 patients (88%), with 6 patients (35.3%) requiring a second intervention and 2 patients (11.8%) undergoing at least 3 interventions.3% patients succumbed to causes directly related to rhinosinusitis, with an average survival of 22 days, and 52.9% patients subsequently passed away due to complications related to their underlying condition, with an average survival of 171 days. Mid-term overall mortality was 88.2%, with an average survival of 111 days. Conclusion: A shift in the patient profile was observed. Less fulminant courses have been evidenced, being oncohematotological disease and solid organ transplantation the main predisposing conditions, instead of poorly controlled diabetes. Even if direct mortality rates from AIFR are reduced (around 35%), the overall mortality rate of these patients is close to 90% with a median survival of less than 6 months. Then, an intense focus on the underlying disease and related complications is essential.Keywords
This publication has 22 references indexed in Scilit:
- Detecting serum galactomannan to diagnose acute invasive Aspergillus sinusitis: a meta-analysisEuropean Archives of Oto-Rhino-Laryngology, 2021
- Usefulness of intraoperative frozen section for diagnosing acute invasive fungal rhinosinusitis: A systematic review and meta‐analysisInternational Forum of Allergy & Rhinology, 2021
- An internally validated diagnostic tool for acute invasive fungal sinusitisInternational Forum of Allergy & Rhinology, 2020
- Avoiding repeated surgery in patients with acute invasive fungal sinusitisEuropean Archives of Oto-Rhino-Laryngology, 2020
- Epidemiology of acute myeloid leukemia: Recent progress and enduring challengesBlood Reviews, 2019
- The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reportsClinical Microbiology and Infection, 2019
- Pathology of Fungal Rhinosinusitis: A ReviewHead and Neck Pathology, 2016
- Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidenceThe Laryngoscope, 2013
- Prognosis of acute invasive fungal rhinosinusitis related to underlying diseaseInternational Journal of Infectious Diseases, 2011
- Role of granulocyte colony-stimulating factor in the treatment of mucormycosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996